Implementing a Therapy for Complex Trauma in French-Speaking Settings
NCT ID: NCT07123974
Last Updated: 2025-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2023-01-22
2025-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A research team in Germany developed and validated a 45-week individual psychotherapy that has shown promising results for individuals coping with both BPD and PTSD. It has already been adapted and offered in English-speaking settings such as Toronto and Boston.
This study aims to adapt this therapy into French in Quebec. Over 24 months, we will conduct a mixed-methods observational study to evaluate changes in symptoms (BPD, PTSD, and other comorbidities) and in daily functioning.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treating PTSD in Patients With Borderline Personality Disorder
NCT01081314
CPT Group for DBT Clients With Co-Occurring Borderline Personality Disorder and PTSD
NCT02574429
Narrative Exposure Therapy in Women With Borderline Personality Disorder and Posttraumatic Stress Disorder
NCT02517723
Evaluation of the Efficacy of "Lifespan Integration" (LI) Therapy in Patients With Complex Post-Traumatic Stress Disorder
NCT06535243
Study of Emotional Dysregulation in Complex Post-Traumatic Stress Disorder
NCT06848127
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dialectical Behaviour Therapy for Post-Traumatic Stress Disorder (DBT-PTSD)
Participants receive the Dialectical Behaviour Therapy for Post-Traumatic Stress Disorder (DBT-PTSD) psychotherapy over 45 weekly individual outpatient sessions. All participants followed the same treatment protocol.
Dialectical Behaviour Therapy for Post-Traumatic Stress Disorder (DBT-PTSD)
DBT-PTSD is 45-week individual psychotherapy (DBT-PTSD) designed to treat adults presenting with both borderline personality disorder (BPD) and complex post-traumatic stress disorder (C-PTSD). The intervention integrates dialectical behavior therapy (DBT) skills, trauma-focused exposure-based interventions, and strategies from compassion-focused therapy and acceptance and commitment therapy. All participants will receive the full sequence of the therapy in outpatient settings, following the structured treatment protocol.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dialectical Behaviour Therapy for Post-Traumatic Stress Disorder (DBT-PTSD)
DBT-PTSD is 45-week individual psychotherapy (DBT-PTSD) designed to treat adults presenting with both borderline personality disorder (BPD) and complex post-traumatic stress disorder (C-PTSD). The intervention integrates dialectical behavior therapy (DBT) skills, trauma-focused exposure-based interventions, and strategies from compassion-focused therapy and acceptance and commitment therapy. All participants will receive the full sequence of the therapy in outpatient settings, following the structured treatment protocol.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Three or more criteria for borderline personality disorder (BPD) according to the SCID-II, including affective instability.
* Availability for one year of outpatient treatment (psychotherapy).
* Access to an email address usable for secure links to questionnaires.
* Fluent French-speaking.
Exclusion Criteria
* Severe suicide attempt within two months prior to the inclusion visit.
* Medical condition preventing inclusion (e.g., pregnancy).
* Highly unstable living situation (e.g., homelessness).
* Current substance dependence.
* Having received specific treatment for PTSD or BPD within the year preceding the inclusion visit.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ciusss de L'Est de l'Île de Montréal
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lionel Cailhol
Role: PRINCIPAL_INVESTIGATOR
Ciusss de l'Est de Montréal, Université de Montréal
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut universitaire en santé mentale de Montréal
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-3031
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.